These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The surgery of malignant melanoma. Apropos 206 cases studied]. Sierra García A An R Acad Nac Med (Madr); 1993; 110(2):321-37. PubMed ID: 8311200 [No Abstract] [Full Text] [Related]
6. [New factors in the clinical aspect of malignant cutaneous melanoma]. Spitalier JM; Amalric R; Ayme Y; Lieutaud R Bull Cancer; 1970; 57(4):403-11. PubMed ID: 4996813 [No Abstract] [Full Text] [Related]
7. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma. van Egmond DB; Welvaart K; Hermans J; Ruiter DJ Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926 [TBL] [Abstract][Full Text] [Related]
8. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742 [No Abstract] [Full Text] [Related]
9. Prognostic factors in 1,521 melanoma patients with distant metastases. Barth A; Wanek LA; Morton DL J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677 [TBL] [Abstract][Full Text] [Related]
10. [To outwit melanoma with its own tricks]. Bischoff A MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255 [No Abstract] [Full Text] [Related]
12. [Epidemiology and prognostic factors in cutaneous malignant melanoma]. Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679 [TBL] [Abstract][Full Text] [Related]
13. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741 [No Abstract] [Full Text] [Related]
14. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry. Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131 [No Abstract] [Full Text] [Related]
15. Prognostic variables for patients with stage III malignant melanoma. Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous melanoma--retrospective study of a small series of patients. Metcalf JS; Hawk JC; Kreutner A J S C Med Assoc; 1981 Mar; 77(3):113-7. PubMed ID: 6938740 [No Abstract] [Full Text] [Related]
17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
18. [The prognosis of patients with level V melanomas of the extremities]. Krüger I; Ghussen F; Groth W Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539 [TBL] [Abstract][Full Text] [Related]
19. [Risk factors for lymph node metastasis in malignant melanoma]. Mussack T; Waldner H; Kharraz-Tavakol A Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332 [TBL] [Abstract][Full Text] [Related]
20. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]